Next-gen biopharmaceuticals are increasingly complex, including antibodies, bispecifics, ADCs, antibody fragments, vaccines, gene/cell therapies and beyond.  Thus, for protein production and purification it is imperative to aim for higher-throughput, to drive automation, and to leverage digital tools to increase productivity, and minimize time and cost. In the Process Technology & Innovation pipeline we bring together leaders from across biopharmaceutical process development to discuss challenges, showcase innovations, and share technical solutions. Attend to learn more.

January 16-17

Higher-Throughput Bioproduction

January 17-18

Training Seminar: Biomanufacturing 101: An Overview on Animal Cell Culture Technology from Cell Line Development to Scale-Up Strategies

January 19-20

Advanced Purification and Recovery

Keynote Presentations:

In silico Facilitated Process Development of Orthogonally Selective Non-Protein A Processes for mAb Bioprocessing
Steven M. Cramer, PhD, William Weightman Walker Professor, Isermann Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute

Advances in Multi-Specific Antibody Purification
John K. Kawooya, PhD, Director, Biologics Optimization and Therapeutic Discovery, Amgen, Inc.

If you are working in the following areas join the PepTalk community: 

• Advanced Automation Technologies
• Biopharmaceutical Development
• Biologics Process Design R&D
• Bioprocess Science and Engineering
• Bioprocess R&D
• Biotechnology Discovery Research
• Data Management and Analytics
• High-Throughput Biologics
• Innovation and Instrumentation
• Process Development & Clinical Manufacturing
• Process Development Analytics
• Process Science
• Process Technology & Innovation
• Product Development & Manufacturing
• Upstream & Downstream Development